(1)
Villalobos Violán, V.; González Cano, B.; Ángel Racionero Casero, M.; González-Mancebo, E.; Mohedano Vicente, E.; Trujillo Trujillo, M. J.; Gandolfo-Cano, M. Real-Life Experience After 3 Months With Tezepelumab before Marketing Approval. Allergol Immunopathol 2023, 52 (2), 80-82. https://doi.org/10.15586/aei.v52i2.1063.